02/23/2024 23:26:43
  • Home | Big Tech meets Big Pharma
  • In this issue
  • Contents
  • Mimotopes Company Insight
  • Mimotopes
  • Proceedix
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Sanofi
  • ILC Dover
  • Nipro
  • ACG Worldwide
  • Comment
  • Covid-19 vaccine effectiveness affected by variants
  • Immuno-oncology high prescriber survey reveals top R&D strategies
  • Using methotrexate may reduce the negative impact of high treatment-related cost
  • Protecting against fake Covid-19 vaccines
  • Cytiva Company Insight
  • Cytiva
  • Datwyler Company Insight
  • Datwyler
  • In Depth
  • Is big pharma and big tech working together a recipe for success?
  • Logging in: how the pharma industry is getting to grips with social media
  • Medical cannabis: regulating a new export market on the Isle of Man
  • Long Covid: could chronic fatigue syndrome be taken seriously at last?
  • Life after Covid-19: four ways to prepare for the next pandemic
  • mRNA vaccines: the post-pandemic outlook after a breakthrough year
  • Staving off AMR disaster with Ineos and the University of Oxford
  • Public benefit: could the PBC model help pharma balance profits and patients?
  • The Solubility Company Insight
  • The Solubility company
  • Butterworth
  • Micronova
  • In Data
  • Inside the deal
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
03/17/2021 00:00:00